Literature DB >> 35546382

Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Emmanuelle A D Schindler1,2.   

Abstract

The therapeutic potential of psychedelics in headache and chronic pain disorders is documented over decades of anecdotal and early investigational reports, which have paved the way for the first controlled studies of psilocybin and lysergic acid diethylamide (LSD) in these disorders. The reported lasting clinical effects after limited dosing with psychedelics present a novel means for disease management, but considerable further study will be required to address disease-specific treatments, uncover mechanism(s) of action, and verify safety. In this chapter, these topics are reviewed with particular attention to the neurobiological systems that offer potential sources of psychedelics' unique clinical effects in headache and pain.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Chronic Pain; Cluster Headache; Headache; LSD; Migraine; Psilocybin; Psychedelics

Mesh:

Substances:

Year:  2022        PMID: 35546382     DOI: 10.1007/7854_2022_365

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  95 in total

1.  Cluster headache: a prospective clinical study with diagnostic implications.

Authors:  Anish Bahra; Arne May; Peter J Goadsby
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

Review 2.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

3.  The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.

Authors:  Rebecca Burch; Paul Rizzoli; Elizabeth Loder
Journal:  Headache       Date:  2018-03-12       Impact factor: 5.887

Review 4.  Acetaminophen/paracetamol: A history of errors, failures and false decisions.

Authors:  K Brune; B Renner; G Tiegs
Journal:  Eur J Pain       Date:  2014-11-27       Impact factor: 3.931

5.  Migraine chronification.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 6.  Migraine and Tension-Type Headache: Diagnosis and Treatment.

Authors:  Rebecca Burch
Journal:  Med Clin North Am       Date:  2018-12-03       Impact factor: 5.456

7.  Diagnostic delays and mis-management in cluster headache.

Authors:  A Bahra; P J Goadsby
Journal:  Acta Neurol Scand       Date:  2004-03       Impact factor: 3.209

Review 8.  Neurostimulation approaches to primary headache disorders.

Authors:  Thorsten Bartsch; Koen Paemeleire; Peter J Goadsby
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

Review 9.  The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.

Authors:  Mansoor M Aman; Ammar Mahmoud; Timothy Deer; Dawood Sayed; Jonathan M Hagedorn; Shane E Brogan; Vinita Singh; Amitabh Gulati; Natalie Strand; Jacqueline Weisbein; Johnathan H Goree; Fangfang Xing; Ali Valimahomed; Daniel J Pak; Antonios El Helou; Priyanka Ghosh; Krishna Shah; Vishal Patel; Alexander Escobar; Keith Schmidt; Jay Shah; Vishal Varshney; William Rosenberg; Sanjeet Narang
Journal:  J Pain Res       Date:  2021-07-16       Impact factor: 3.133

10.  Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.

Authors:  Martin Andersson; Mari Persson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2017-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.